Form 4: NeueHealth Executive Exercises Stock Options
SEC Form 4
Jeffrey J. Scherman, Chief Accounting Officer of NeueHealth, Inc., reports the vesting and conversion of restricted stock units into common stock.
Summary
- On May 9, 2025, Jeffrey J. Scherman, the Chief Accounting Officer of NeueHealth, Inc., executed transactions related to restricted stock units.
- Specifically, 341 restricted stock units vested and were converted into 341 shares of common stock.
- Following the transaction, Scherman directly owns 12,575 shares of NeueHealth common stock.
- The restricted stock units vested in three equal installments on May 9, 2023, May 9, 2024, and May 9, 2025.
Sentiment
Score: 5
Explanation: This is a neutral reporting of a standard executive compensation transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the holdings of company insiders.
Stakeholder Impact
- The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| May 9, 2023 | One-third of the restricted stock units vested. |
| May 9, 2024 | One-third of the restricted stock units vested. |
| May 9, 2025 | Final one-third of the restricted stock units vested and were converted into 341 shares of common stock; transaction date. |
| May 13, 2025 | Date of the report filing. |
Keywords
NeueHealth, Scherman, Restricted Stock Units, Common Stock, Beneficial Ownership, Form 4, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.